Objective To evaluate the effectiveness and safety of medical sodium hyaluronate gels on the prevention of postoperative adhesion after abdominal and pelvic operation in the Department of general surgery, and discuss its clinical practical value. Methods Total 521 patients undergoing pelvic and abdominal operation were selected and randomly divided into experimental group(263cases)and control group(258cases).The sodium hyaluronate gels were used in the experimental group to coat over the operative area and adjacent parts, but not in the control group. After the surgery, the recorded data was analyzed statisticaly. Results In the experimental group: the mean time for passage of stools(19.8±1.7)h, the leucocyte count increased:8.0%(21cases),physical examination with the pain and discomfort:6.8%(18cases),post-operative adhesion:16cases included 3 cases of type Ⅰ and 13 cases of type Ⅱ.In the control group: the mean time for passage of stools(37.1±3.6)h, the leucocyte count increase:40.7%(105cases),physical examination with the pain and discomfort:24.0%(62cases),post-operative adhesion:94 cases include 39 cases of type Ⅰ and 55 cases of type Ⅱ.Conclusion The sodium hyaluronate gels may decrease the risk of postoperative adhesion formation, reduce the incidence of postoperative infection, pain, discomfort and other symptoms. It is worthy of clinical application and promotion.
Reference from Chinese Journal of General Practice
Writer: Gu Qiu-zhong, the First people's Hospital of Pinghu, Zhejiang, China.
-
singclean | 2017-08-14
Singclean Medical to Debut Singderm® at IMCAS China 2026 – A PreviewShanghai, August 2026 – The 5th IMCAS China Congress is set to open on August 27–29, 2026 at the W Shanghai – The Bund. As one of the most anticipated gatherings in medical aesthetics, the event will bring together global experts, innovators, and clinicians. Among the featured exhibitors, Hangzhou Singclean Medical Products Co., Ltd. will make a strong impression by unveiling its premium hyaluronic acid filler Singderm® to the international community. -
singclean | 2017-08-14
Singclean to Showcase Comprehensive Healthcare Solutions at IMCAS China 2026, MEDITECH 2026 and MEDICAL FAIR ASIA 2026As part of its continued global expansion, Singclean Medical will participate in three major international healthcare exhibitions across Asia and Latin America in the second half of 2026: IMCAS China 2026 in Shanghai, MEDITECH 2026 in Bogotá, and MEDICAL FAIR ASIA 2026 in Singapore. These events provide valuable opportunities to connect with healthcare professionals, distributors, and industry partners while presenting Singclean's latest innovations in biomaterials and medical technology. -
singclean | 2017-08-14
Singclean Medical to Showcase Innovative Healthcare Solutions at WHX Bangkok 2026 and Meditech Colombia 2026Hangzhou, China | July 2026 Singclean Medical will participate in two leading international healthcare exhibitions this July—WHX Bangkok 2026 in Thailand and Meditech Colombia 2026 in Colombia—continuing its commitment to expanding its global presence and strengthening partnerships across Southeast Asia and Latin America.